Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers

Translational Research

Volumn 162, Issue 2, 2013, Pages 102-109

  Sanchis Gomar, Fabian ^a   Bonaguri, Chiara ^b   Aloe, Rosalia ^b   Pareja Galeano, Helios ^a   Martinez Bello, Vladimir ^a   Gomez Cabrera, Mari Carmen ^a   Candel, Jorge ^c   Viña, Jose ^a   Lippi, Giuseppe ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c Valencia CF Medical Services   (Spain)

Author keywords

ADM; adrenomedullin; GDF15; growth differentiation factor 15; midregional part of proadrenomedullin; MR proADM; placental growth factor; PlGF; sVEGFR 1 sFLT 1; UA; uric acid; vascular endothelial growth factor; vascular endothelial growth factor receptor 1; VEGF; xanthine oxidase; XO

Indexed keywords

ALLOPURINOL; COPEPTIN; GROWTH DIFFERENTIATION FACTOR 15; PLACEBO; PLACENTAL GROWTH FACTOR; PROADRENOMEDULLIN; URIC ACID; VASCULOTROPIN RECEPTOR; XANTHINE OXIDASE;

ADULT; ARTICLE; ATHLETE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME INHIBITION; EXERCISE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRESS; VENOUS BLOOD;

EID: 84880573004     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.02.006     Document Type: Article

References (71)

1. P. Brancaccio, G. Lippi, and N. Maffulli Biochemical markers of muscular damage Clin Chem Lab Med 48 2010 757 767
2. G. Lippi, F. Schena, M. Montagnana, G.L. Salvagno, and G.C. Guidi Influence of acute physical exercise on emerging muscular biomarkers Clin Chem Lab Med 46 2008 1313 1318
3. T.M. Eijsvogels, R. Shave, A. van Dijk, M.T. Hopman, and D.H. Thijssen Exercise-induced cardiac troponin release: real-life clinical confusion Curr Med Chem 18 2011 3457 3461
4. G. Lippi, G. Cervellin, G. Banfi, and M. Plebani Cardiac troponins and physical exercise. It's time to make a point Biochem Med (Zagreb) 21 2011 55 62
5. G. Lippi, F. Schena, G.L. Salvagno, C. Tarperi, R. Aloe, and G.C. Guidi Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners J Thromb Thrombolysis 33 2011 338 342
6. G. Lippi, F. Schena, and M. Dipalo Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run Scand J Clin Lab Invest 72 2012 467 470
7. G. Lippi, F. Schena, M. Montagnana, G.L. Salvagno, G. Banfi, and G.C. Guidi Significant variation of traditional markers of liver injury after a half-marathon run Eur J Intern Med 22 2011 e36 e38
8. K. Yared, and M.J. Wood Is marathon running hazardous to your cardiovascular health? The jury is still out Radiology 251 2009 3 5
9. B. Ibrahim, and P.J. Stoward The histochemical localization of xanthine oxidase Histochem J 10 1978 615 617
10. K.J. Davies, A.T. Quintanilha, G.A. Brooks, and L. Packer Free radicals and tissue damage produced by exercise Biochem Biophys Res Commun 107 1982 1198 1205
11. M.C. Gomez-Cabrera, C. Borras, F.V. Pallardo, J. Sastre, L.L. Ji, and J. Vina Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats J Physiol 567 2005 113 120
12. M.C. Gomez-Cabrera, E. Domenech, and M. Romagnoli Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance Am J Clin Nutr 87 2008 142 149
13. H. Tsutsui, S. Kinugawa, and S. Matsushima Oxidative stress and heart failure Am J Physiol Heart Circ Physiol 301 2011 H2181 H2190
14. P.C. Moorhouse, M. Grootveld, B. Halliwell, J.G. Quinlan, and J.M. Gutteridge Allopurinol and oxypurinol are hydroxyl radical scavengers FEBS Lett 213 1987 23 28
15. M.C. Gomez-Cabrera, A. Martinez, G. Santangelo, F.V. Pallardo, J. Sastre, and J. Vina Oxidative stress in marathon runners: interest of antioxidant supplementation Br J Nutr 96 Suppl 1 2006 S31 S33
16. G. Banfi, A. Colombini, G. Lombardi, and A. Lubkowska Metabolic markers in sports medicine Adv Clin Chem 56 2012 1 54
17. F.M. de Bree, and J.P. Burbach Structure-function relationships of the vasopressin prohormone domains Cell Mol Neurobiol 18 1998 173 191
18. M. Katan, N. Morgenthaler, and I. Widmer Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level Neuro Endocrinol Lett 29 2008 341 346
19. T. Reichlin, W. Hochholzer, and C. Stelzig Incremental value of copeptin for rapid rule out of acute myocardial infarction J Am Coll Cardiol 54 2009 60 68
20. T. Keller, S. Tzikas, and T. Zeller Copeptin improves early diagnosis of acute myocardial infarction J Am Coll Cardiol 55 2010 2096 2106
21. E. Giannitsis, T. Kehayova, M. Vafaie, and H.A. Katus Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction Clin Chem 57 2011 1452 1455
22. S. Charpentier, F. Maupas-Schwalm, M. Cournot, M. Elbaz, J.M. Botella, and D. Lauque Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department Acad Emerg Med 19 2012 517 524
23. G. Lippi, R. Aloe, M. Dipalo, and G. Cervellin Combination of copeptin and highly sensitive troponin I for diagnosing acute myocardial infarction at emergency department admission Clin Lab 58 2012 357 358 author reply 9-60
24. S.Q. Khan, O.S. Dhillon, and R.J. O'Brien C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study Circulation 115 2007 2103 2110
25. S. Neuhold, M. Huelsmann, and G. Strunk Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease J Am Coll Cardiol 52 2008 266 272
26. L. Balling, C. Kistorp, and M. Schou Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses J Card Fail 18 2012 351 358
27. I. Tentzeris, R. Jarai, and S. Farhan Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure Eur J Heart Fail 13 2011 726 733
28. A. Luchner Copeptin for acute coronary syndrome: diamond or decoy? Clin Chem Lab Med 50 2012 191 192
29. D.W. Kehl, N. Iqbal, A. Fard, B.A. Kipper, A. De La Parra Landa, and A.S. Maisel Biomarkers in acute myocardial injury Transl Res 159 2012 252 264
30. S. Enhorning, T.J. Wang, and P.M. Nilsson Plasma copeptin and the risk of diabetes mellitus Circulation 121 2010 2102 2108
31. M. Katan, and M. Christ-Crain The stress hormone copeptin: a new prognostic biomarker in acute illness Swiss Med Wkly 140 2010 w13101
32. M. Kolditz, M. Halank, B. Schulte-Hubbert, S. Bergmann, S. Albrecht, and G. Hoffken Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia Respir Med 106 2012 1320 1328
33. A. Meisel, C. Meisel, H. Harms, O. Hartmann, and L. Ulm Predicting post-stroke infections and outcome with blood-based immune and stress markers Cerebrovasc Dis 33 2012 580 588
34. Q. Lin, F. Fu, H. Chen, and B. Zhu Copeptin in the assessment of acute lung injury and cardiogenic pulmonary edema Respir Med 106 2012 1268 1277
35. J.P. Hinson, S. Kapas, and D.M. Smith Adrenomedullin, a multifunctional regulatory peptide Endocr Rev 21 2000 138 167
36. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
37. P.S. Wild, R.B. Schnabel, and E. Lubos Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study Clin Chem 58 2011 226 236
38. F.P. Brouwers, R.A. de Boer, and P. van der Harst Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population Heart 98 2012 1348 1353
39. S. von Haehling, G.S. Filippatos, and J. Papassotiriou Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure Eur J Heart Fail 12 2010 484 491
40. M. Katan, F. Fluri, and P. Schuetz Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke J Am Coll Cardiol 56 2010 1045 1053
41. G. Palladini, A. Barassi, and S. Perlini Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis Amyloid 18 2011 216 221
42. M. Christ-Crain, N.G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann, and B. Muller Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study Crit Care 9 2005 R816 R824
43. S. Bello, A.B. Lasierra, and E. Minchole Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology Eur Respir J 39 2011 1144 1155
44. M. Sarda Sanchez, J. Calzada Hernandez, S. Hernandez Bou, G. Claret Teruel, J. Velasco Rodriguez, and C. Luaces Cubells Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminary prospective observational study BMC Res Notes 5 2012 363
45. A. Maisel, C. Mueller, and R.M. Nowak Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 58 2011 1057 1067
46. O. Cinar, E. Cevik, and A. Acar Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of ED patients with dyspnea Am J Emerg Med 30 2012 1915 1920
47. R.V. Shah, Q.A. Truong, H.K. Gaggin, J. Pfannkuche, O. Hartmann, and J.L. Januzzi Jr. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea Eur Heart J 33 2012 2197 2205
48. M.T. Maeder, M.H. Brutsche, and N. Arenja Biomarkers and peak oxygen uptake in patients with chronic lung disease Respiration 80 2010 543 552
49. D. Schlittenhardt, A. Schober, and J. Strelau Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions Cell Tissue Res 318 2004 325 333
50. E.C. Hsiao, L.G. Koniaris, T. Zimmers-Koniaris, S.M. Sebald, T.V. Huynh, and S.J. Lee Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury Mol Cell Biol 20 2000 3742 3751
51. M. Albertoni, P.H. Shaw, and M. Nozaki Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 Oncogene 21 2002 4212 4219
52. E.C. Breen, E.C. Johnson, H. Wagner, H.M. Tseng, L.A. Sung, and P.D. Wagner Angiogenic growth factor mRNA responses in muscle to a single bout of exercise J Appl Physiol 81 1996 355 361
53. T. Gustafsson, A. Puntschart, L. Kaijser, E. Jansson, and C.J. Sundberg Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle Am J Physiol 276 1999 H679 H685
54. R.S. Richardson, H. Wagner, S.R. Mudaliar, R. Henry, E.A. Noyszewski, and P.D. Wagner Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise Am J Physiol 277 1999 H2247 H2252
55. M. Autiero, A. Luttun, M. Tjwa, and P. Carmeliet Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders J Thromb Haemost 1 2003 1356 1370
56. P. Carmeliet, L. Moons, and A. Luttun Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat Med 7 2001 575 583
57. M. Shibuya Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1) Int J Biochem Cell Biol 33 2001 409 420
58. T. Li, Y. Zhu, and C.Y. Qin Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma J Clin Pathol 65 2012 808 814
59. H.P. Dhakal, B. Naume, and M. Synnestvedt Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness Histopathology 61 2012 350 364
60. A. Suryawanshi, T. Veiga-Parga, P.B. Reddy, N.K. Rajasagi, and B.T. Rouse IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection J Immunol 188 2012 3434 3446
61. A.L. Harris, P. Reusch, B. Barleon, C. Hang, N. Dobbs, and D. Marme Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy Clin Cancer Res 7 2001 1992 1997
62. W. Jelkmann Pitfalls in the measurement of circulating vascular endothelial growth factor Clin Chem 47 2001 617 623
63. T. Hew-Butler, M.D. Hoffman, K.J. Stuempfle, I.R. Rogers, N.G. Morgenthaler, and J.G. Verbalis Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia Clin J Sport Med 21 2011 211 217
64. J. Burge, B. Knechtle, P. Knechtle, M. Gnadinger, C.A. Rust, and T. Rosemann Maintained serum sodium in male ultra-marathoners-the role of fluid intake, vasopressin, and aldosterone in fluid and electrolyte regulation Horm Metab Res 43 2011 646 652
65. P. L'Abate, S. Wiegert, J. Struck, S. Wellmann, and V. Cannizzaro Determinants of plasma copeptin: A systematic investigation in a pediatric mechanical ventilation model Respir Physiol Neurobiol 185 2013 222 227
66. S. Montoro-Garcia, D. Hernandez-Romero, and E. Jover Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy Eur J Intern Med 23 2012 169 174
67. P.S. Munk, T. Valborgland, N. Butt, and A.I. Larsen Response of growth differentiation factor-15 to percutaneous coronary intervention and regular exercise training Scand Cardiovasc J 45 2011 27 32
68. R. Stahrenberg, F. Edelmann, and M. Mende The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction Eur J Heart Fail 12 2010 1309 1316
69. I. Tchou, A. Margeli, and M. Tsironi Growth-differentiation factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race Biomarkers 14 2009 418 422
70. A.P. Bailey, M. Shparago, and J.W. Gu Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers Med Sci Monit 12 2006 CR45 CR50
71. R. Kivela, M. Silvennoinen, M. Lehti, S. Jalava, V. Vihko, and H. Kainulainen Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice Cardiovasc Diabetol 7 2008 13